Efficacy and Safety of Taeeumjowi-tang in Obese Korean Adults: A Double-Blind, Randomized, and Placebo-Controlled Pilot Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Sunju | - |
dc.contributor.author | Nahmkoong, Won | - |
dc.contributor.author | Cheon, ChunHoo | - |
dc.contributor.author | Park, Jeong-Su | - |
dc.contributor.author | Jang, Bo-Hyoung | - |
dc.contributor.author | Shin, Yongcheol | - |
dc.contributor.author | Kim, Kyung-Soo | - |
dc.contributor.author | Go, Hoyeon | - |
dc.contributor.author | Song, Yun-Kyung | - |
dc.contributor.author | Ko, Seong-Gyu | - |
dc.date.available | 2020-02-29T04:43:19Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1741-427X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/15904 | - |
dc.description.abstract | Objective. The purpose of this study was to assess the efficacy and safety of Taeeumjowi-tang (TJ001) as well as to estimate obesity-related factors. Methods. This was a 12-week trial with 5 visits. A total of 102 participants of both genders were randomized to either TJ001 (n = 57) group or the placebo group (n = 55). Subjects were administered 7 g of either TJ001 or placebo 3 times a day. The primary outcome was a rate of subjects who lost 5% or more of initial weight. Secondary outcomes included anthropometric parameters, lipid profiles, and body fat composition. Results. The subject response rate of = 5% weight loss compared to baseline was similar in both groups, and no statistically significant difference was observed (n = 0.87). Changes in anthropometric parameters were greater during the first 4 weeks in the treatment group (n < 0.0001). There were no significant changes in both within groups and between groups for lipid profile and body fat composition. No adverse event was reported in either group. Conclusion. Although the difference between the groups regarding a rate of subjects who lost 5% or more of initial weight did not show statistical significance, TJ001 appears to be beneficial in safely controlling weight. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | HINDAWI LTD | - |
dc.relation.isPartOf | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.subject | BLOOD-PRESSURE | - |
dc.subject | WEIGHT-LOSS | - |
dc.title | Efficacy and Safety of Taeeumjowi-tang in Obese Korean Adults: A Double-Blind, Randomized, and Placebo-Controlled Pilot Trial | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000324187900001 | - |
dc.identifier.doi | 10.1155/2013/498935 | - |
dc.identifier.bibliographicCitation | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.identifier.scopusid | 2-s2.0-84884229580 | - |
dc.citation.title | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.contributor.affiliatedAuthor | Song, Yun-Kyung | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | BLOOD-PRESSURE | - |
dc.subject.keywordPlus | WEIGHT-LOSS | - |
dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.